Mucus Relief Dm Extended Release Caplets Tablet, Extended Release
Product Images NDC 0536-1161

1 FDA label image from Rugby Laboratories · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Mucus Relief Dm Extended Release Caplets (NDC 0536-1161). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rugby Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Dextromethorphan Hbr 30 mg, Guaifenesin 600 mg (Mucus Relief Dm 600 mg 30 mg Extended Release Capl 1)

Dextromethorphan Hbr 30 mg, Guaifenesin 600 mg (Mucus Relief Dm 600 mg 30 mg Extended Release Capl 1)
Mucus Relief DM Extended Release tablets packaging label showing Rugby Laboratories as the labeler. Each tablet contains 600 mg Guaifenesin (expectorant) and 30 mg Dextromethorphan HBr (cough suppressant). The carton contains 20 extended-release tablets and highlights 12-hour relief, cough control, and mucus thinning. The label includes usage, warnings, directions, and inactive ingredients information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.